These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 9720504

  • 21. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P, De Matteo E, Merediz A, Preciado MV.
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [Abstract] [Full Text] [Related]

  • 22. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
    Correa RM, Fellner MD, Alonio LV, Durand K, Teyssié AR, Picconi MA.
    J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China.
    van Gorp J, Weiping L, Jacobse K, Liu YH, Li FY, De Weger RA, Li G.
    J Pathol; 1994 Jun; 173(2):81-7. PubMed ID: 7522272
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA, Zekri AR, Asaad N, El-Houssini S, Khalid HM, Sedky LM, Mokhtar NM.
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [Abstract] [Full Text] [Related]

  • 28. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
    Kuo TT, Shih LY, Tsang NM.
    Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse HJ, Gisselbrecht C, Marelle L, van Krieken HJ, Pallesen G.
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [Abstract] [Full Text] [Related]

  • 30. Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.
    García-Cosío M, Santón A, Méndez MC, Rivas C, Martín C, Bellas C.
    Tumori; 2003 Oct; 89(3):278-84. PubMed ID: 12908783
    [Abstract] [Full Text] [Related]

  • 31. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
    Petit B, Leroy K, Kanavaros P, Boulland ML, Druet-Cabanac M, Haioun C, Bordessoule D, Gaulard P.
    Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
    [Abstract] [Full Text] [Related]

  • 32. Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan.
    Hirose Y, Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawabata H, Fukushima T, Ogawa N, Wano Y, Umehara H.
    Eur J Haematol; 2006 Feb; 76(2):109-18. PubMed ID: 16405431
    [Abstract] [Full Text] [Related]

  • 33. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH, Cho EY, Kim JE, Lee SS, Huh JR, Chang HK, Yang WI, Kim CW, Kim SW, Ree HJ.
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, Greiner TC.
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [Abstract] [Full Text] [Related]

  • 38. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [Abstract] [Full Text] [Related]

  • 39. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
    Mori N, Yatabe Y, Oka K, Kinoshita T, Kobayashi T, Ono T, Asai J.
    Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
    [Abstract] [Full Text] [Related]

  • 40. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
    Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T, Kon S.
    Cancer; 1996 May 15; 77(10):2137-49. PubMed ID: 8640683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.